Chanmei Lv Jiantao Lv Yue Liu Qifeng Liu Dongna Zou
10.1177/2058738420925713
Int J Immunopathol Pharmacol
2020 Jan-Dec;34:2058738420925713.
acute hematogenous osteomyelitis (aho) methicillin-resistant staphylococcus aureus (mrsa) pharmaceutical care vancomycin serum concentrations
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32567423/
Anti-Bacterial Agents / therapeutic use Methicillin-Resistant Staphylococcus aureus Osteomyelitis / drug therapy Staphylococcal Infections / drug therapy Vancomycin / therapeutic use
Anti-Bacterial Agents / therapeutic use Methicillin-Resistant Staphylococcus aureus Osteomyelitis / drug therapy Staphylococcal Infections / drug therapy Vancomycin / therapeutic use Case Reports Anti-Bacterial Agents / administration & dosage Anti-Bacterial Agents / adverse effects C-Reactive Protein / analysis Child Female Humans Leukocyte Count Neutrophils Osteomyelitis / etiology Osteomyelitis / surgery Staphylococcal Infections / complications Staphylococcal Infections / surgery Treatment Outcome Vancomycin / administration & dosage Vancomycin / adverse effects Anti-Bacterial Agents Vancomycin C-Reactive Protein
PMC7307395
32567423
Pediatric pharmaceutical care with anti-infective medication in a patient with acute hematogenous osteomyelitis caused by methicillin-resistant Staphylococcus aureus
2020